StonvexLoading…
StonvexStonvexStonvexCore line items from BSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $5.45B | $5.20B | $20.07B | $14.79B | $9.72B |
Operating Income | Not available | $1.10B | $3.61B | $2.79B | $1.74B |
Net Income | Not available | $1.34B | $2.89B | $2.22B | $1.47B |
EPS (Diluted) | $0.84 | $0.90 | $1.94 | $1.49 | $0.98 |
Total Assets | Not available | $44.35B | $43.67B | $42.71B | $41.56B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $1.45B | $1.97B | $1.27B | $534.00M |
Free Cash Flow OCF − CapEx | Not available | $171.00M | $3.66B | $2.65B | $1.48B |
Shares Outstanding | Not available | 1.50B | 1.49B | 1.49B | 1.49B |